In breast cancer, BRD4 reorganises chromatin and facilitates recruitment of the LSD1–NuRD complex to SEs, which in turn with BRD4 occupies SEs, thereby repressing genes, and is functionally linked to drug resistance. This evidence concerns the gene BRD4 and breast carcinoma.